We are live on
!
Find out more
CCM
Courage Capital Management Portfolio holdings
AUM
$67.3M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+9.93%
3 Year Est. Return
+86.55%
5 Year Est. Return
+93.16%
10 Year Est. Return
+8,077.67%
AUM
$185M
AUM Growth
+$50.8M
(+38%)
Cap. Flow
+$48.8M
Cap. Flow
% of AUM
26.45%
Top 10 Holdings %
Top 10 Hldgs %
92.3%
Holding
29
New
4
Increased
4
Reduced
4
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HNGR
Hanger Inc.
HNGR
|
+$54.3M |
| 2 |
Acadia Healthcare
ACHC
|
+$3.39M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.86M |
| 4 |
MIK
Michaels Stores, Inc
MIK
|
+$1.9M |
| 5 |
Capri Holdings
CPRI
|
+$980K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$7.05M |
| 2 |
NovoCure
NVCR
|
+$6.17M |
| 3 |
HSTO
Histogen Inc. Common Stock
HSTO
|
+$428K |
| 4 |
CRISPR Therapeutics
CRSP
|
+$423K |
| 5 |
Editas Medicine
EDIT
|
+$301K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.46% |
| 2 | Technology | 27.68% |
| 3 | Miscellaneous | 9.32% |
| 4 | Real Estate | 7.77% |
| 5 | Communication Services | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CRISPR Therapeutics
CRSP
$5.12B
| – | – |
-7,200
| Closed | -$423K |
|
|
27
Editas Medicine
EDIT
$415M
| – | – |
-8,400
| Closed | -$301K |
|
28
Galectin Therapeutics
GALT
$394M
| – | – |
-22,126
| Closed | -$141K |
|
|
JONE
29
DELISTED
Jones Energy, Inc.
JONE
| – | – |
-1,893
| Closed | -$14K |
|
Similar funds
FWA
PCA
2P
TCM
BI
CSMC
VM
EPCM
Courage Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Courage Capital Management held 29 positions worth $185M, up 38% from $134M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Courage Capital Management deployed $48.8M of net new capital in Q3 2018, opening 4 new positions and adding to 4 existing holdings. Its largest new stake was Hanger Inc.: 2,507,923 shares worth $52.2M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 22% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Altaba Inc, an estimated $7.05M trimmed.
- Courage Capital Management's largest Q3 2018 buy was Hanger Inc.: 2,507,923 shares worth $52.2M.
- Courage Capital Management added most to Acadia Healthcare in Q3 2018, an estimated $3.39M increase.
- Courage Capital Management's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $7.05M.
- Courage Capital Management fully exited CRISPR Therapeutics in Q3 2018, selling an estimated $423K.
- Courage Capital Management's ten largest holdings make up 92% of its $185M portfolio in Q3 2018.
- Courage Capital Management opened 4 new positions and closed 5 in Q3 2018.
- Courage Capital Management's portfolio value rose 38% quarter-over-quarter to $185M.
Based on Courage Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.